Assessment of mouth-level exposure to tobacco constituents in u.s. Snus consumers

Nicotine and Tobacco Research

Volumn 15, Issue 3, 2013, Pages 670-677

  Caraway, John W ^a   Chen, P X ^a  

^a R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABASINE DERIVATIVE; ARSENIC; BENZO[A]PYRENE; CADMIUM; CHROMIUM; LEAD; NICKEL; NICOTINE; NITROSONORNICOTINE; TRACE METAL;

ADULT; ARTICLE; BEHAVIOR; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONSUMER; EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH LEVEL EXPOSURE; PRIORITY JOURNAL; SELF REPORT; SMOKING; TIME; TOBACCO; UNITED STATES;

ADULT; BENZO(A)PYRENE; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; METALS, HEAVY; MIDDLE AGED; MOUTH; NICOTINE; NITROSAMINES; SMOKING; TOBACCO, SMOKELESS; UNITED STATES; YOUNG ADULT;

EID: 84874098717     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts187     Document Type: Article

References (30)

1. Andersson, G., Björnberg, G., & Curvall, M. (1994). Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: A comparative study. Journal of Oral Pathology & Medicine, 23, 161-167. doi:10.1111/ j.1600-0714.1994.tb01106.x
2. Biener, L., & Bogen, K. (2009). Receptivity to Taboka and Camel snus in a U.S. test market. Nicotine & Tobacco Research, 11, 1154-1159. doi: 10.1093/ntr/ntp113
3. Digard, H., Errington, G., Richter, A., & McAdam, K. (2009). Patterns and behaviors of snus consumption in Sweden. Nicotine & Tobacco Research, 11, 1175-1181. doi: 10.1093/ ntr/ntp118
4. Feyerabend, C., Higenbottam, T., & Russell, M. A. (1982). Nicotine concentrations in urine and saliva of smokers and non-smokers. British Medical Journal, 284, 1002-1004. doi:10.1136/bmj.284.6321.1002
5. Foulds, J., Ramstrom, L., Burke, M., & Fagerström, K. (2003). Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control, 12, 349-359. doi:10.1136/tc.12.4.349
6. Fowler, K. W., Bombick, B. R., Hill-Hart, J. A., Arimilli, S., & Prasad, G. L. (2012). Standardization of the preparation of smokeless tobacco extracts for assessment of biological effect. Unpublished manuscript.
7. Health Canada. (1999a). Determination of alkaloids in whole tobacco. Health Canada-Official Method T-301. Ottawa, ON, Canada: Health Canada. Retrieved from www.hc-sc.gc.ca/hc-ps/alt_formats/hecs-sesc/pdf/tobac-tabac/legislation/reg/indust/method/_whole-entier/alkaloids-eng.pdf
8. Health Canada. (1999b). Determination of nitrosamines in whole tobacco. Health Canada-Official Method T-309. Ontario, Canada: Health Canada.
9. Health Canada. (1999c). Determination of benzo[a]pyrene in whole tobacco. Health Canada-Official Method T-307. Ontario, Canada: Health Canada.
10. Health Canada. (1999d). Determination of Ni, Pb, Cd, Cr, As, Se and Hg in whole tobacco. Health Canada-Official Method T-306. Ontario, Canada: Health Canada.
11. Hecht, S. S., Ornaf, R. M., & Hoffmann, D. (1975). Chemical studies on tobacco smoke. XXXIII. N?-nitrosonornicotine in tobacco: Analysis of possible contributing factors and biologic implications. Journal of the National Cancer Institute, 54, 1237-1244.
12. Jarczyk, L., Maier, H., Born, I. A., Scherer, G., & Adlkofer, F. (1991). Concentration of nicotine in serum and saliva after intravenous infusion of the alkaloid and after smoking. In F. Adlkofer & K. Thurau (Eds.), Effects of nicotine on biological systems (pp. 51-55). Basel, Switzerland: Birkhäuser Verlag.
13. Lee, P. N., & Hamling, J. (2009). Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Medicine, 7, 36. doi:10.1186/1741-7015-7-36
14. Levy, D. T., Mumford, E. A., Cummings, K. M., Gilpin, E. A., Giovino, G., Hyland, A.,... Warner, K. E. (2004). The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts. Cancer Epidemiology, Biomarkers & Prevention, 13, 2035-2042.
15. Lunell, E., & Curvall, M. (2011). Nicotine delivery and subjective effects of Swedish portion snus compared with 4mg nicotine polacrilex chewing gum. Nicotine & Tobacco Research, 13, 573-578. doi:10.1093/ntr/ntr044
16. Lunell, E., & Lunell, M. (2005). Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study. Nicotine & Tobacco Research, 7, 397-403. doi:10.1080/14622200500125468
17. Nair, J., Ohshima, H., Friesen, M., Croisy, A., Bhide, S. V., & Bartsch, H. (1985). Tobacco-specific and betel nut-specific N-nitroso compounds: Occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis, 6, 295-303. doi:10.1093/carcin/6.2.295
18. Ogden, M. O. (2011). Establishing an FDA list of harmful and potentially harmful tobacco product constituents. Update Magazine, Food and Drug Law Institute, 3, 10-15.
19. Osterdahl, B. G., & Slorach, S. (1988). Tobacco-specific Nnitrosamines in the saliva of habitual male snuff dippers. Food Additives and Contaminants, 5, 581-586.
20. Roth, D. H., Roth, A. B., & Liu, X. (2005). Health risks of smoking compared to Swedish snus. Inhalation Toxicology, 17, 741-748.
21. Royal College of Physicians. (2007). Harm reduction in nicotine addiction: Helping people who can't quit. London: Tobacco Advisory Group, Royal College of Physicians.
22. Rutqvist, L. E., Curvall, M., Hassler, T., Ringberger, T., & Wahlberg, I. (2011). Swedish snus and the GothiaTek standard. Harm Reduction Journal, 8, 11. doi:10.1186/ 1477-7517-8-11
23. Schildt, E. B., Eriksson, M., Hardell, L., & Magnuson, A. (1998). Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. International Journal of Cancer, 77, 341-346. doi:10.1002/(SICI)1097-0215(19980729)77:3<341:: AID-IJC6>3.0.CO;2-O
24. Stepanov, I., Biener, L., Knezevich, A., Nyman, A. L., Bliss, R., Jensen, J.,... Hatsukami, D. K. (2012). Monitoring tobaccospecific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: Findings from Round 1 of the New Product Watch. Nicotine & Tobacco Research, 14, 274-281. doi:10.1093/ntr/ntr209
25. Stratton, K., Shetty, P., Wallace, R., & Bondurant, S. (2001). Clearing the smoke: Assessing the science base for tobacco harm reduction. Washington, DC: National Academies Press.
26. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2008). Results from the 2007 National Survey on Drug Use and Health: Detailed tables. Retrieved from: www.oas.samhsa.gov/NSDUH/2k7NSDUH/tabs/Sect2peTabs1to42.htm#Tab2.31A
27. Tso, T. C. (1990). The production of tobacco. In Production, physiology, and biochemistry of tobacco plant. (pp. 55-64). New York, NY: Ideals.
28. U.S. Department of Health and Human Services. (2004). The health consequences of smoking: A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
29. Wenke, G., Brunnemann, K. D., Hoffmann, D., & Bhide, S. V. (1984). A study of betel quid carcinogenesis. IV. Analysis of the saliva of betel chewers: A preliminary report. Journal of Cancer Research and Clinical Oncology, 108, 110-113. doi:10.1007/BF00390981
30. Zeller, M., Hatsukami D., Backinger, C., Benowitz, N., Biener, L., Burns, D., Warner, K. (2009). The strategic dialogue on tobacco harm reduction: A vision and blueprint for action in the US. Tobacco Control, 18, 324-332. doi:10.1136/tc.2008.027318